Cut costs and keep talent with smarter GLP-1 care
Embla helps you offer the weight loss benefit employees want — without the unsustainable cost. Our coaching-led model delivers better long-term results using 66% less GLP-1s.
GLP-1 pressure is growing fast
Why most GLP-1 coverage backfires
High-dose prescriptions with no controls overwhelm self-funded budgets.
No coaching means poor adherence, low impact, and inevitable weight regain.
When behavior doesn’t change, medication alone doesn’t last.
Embla is a better way to offer GLP-1s
We combine low-dose GLP-1s, 1:1 behavioral coaching, and structured tapering to deliver long-term weight loss at a fraction of the cost — with no admin burden for your team.
Boosted engagement
Employees connect with 1:1 coaches, log progress in-app, and stay motivated through expert support.
Measurable health gains
From weight loss to mental resilience — our coaching improves the whole person, not just the number on the scale.
Controlled costs
We keep members in lower GLP-1 tiers and taper early, saving $4,800–$7,800 per employee annually.
Better performance
Healthier employees miss fewer days, perform better, and feel more confident at work.
Our programs
EmblaThrive
Coaching-first care based on CBT and ACT — supporting employees with nutrition, movement, mindset, and emotional eating without medication.
EmblaThriveMD
We add low-dose GLP-1s to the Thrive foundation, combining medication with behavioral change for better, lasting results.
Embla Embrace
Our maintenance program supports employees post-medication with on-demand coaching and habit reinforcement.
Launch in 7 days. Fully managed.
1. Meet with us
We’ll tailor the program to your population.
2. We take care of everything
Onboarding, prescribing, engagement, and reporting — fully managed.
3. Go live in 7 days
Fast, scalable launch. Full-service. No admin burden.
Backed by real-world clinical data
Our 2023 TRIM study of over 2,700 participants proves that lower GLP-1 doses combined with coaching deliver better, longer-lasting result, while preventing costly weight regain post-medication.
Real-world results,
Real-world savings
We keep employees on the lowest effective dose — saving thousands per person.
Outperforms GLP-1s alone by 40–85%.
Lower A1c, cholesterol, blood pressure, inflammation — and fewer obesity-related claims.
Ready to take control of GLP-1 spend?
Let’s talk about how Embla can reduce costs and improve health outcomes for your workforce.